Worth repeating because this is HUGE!!!!Keith"we are preparing for future EPIDIOLEX generic launch for the US market...He also discussed the unique place MPL is in with potential DEA rescheduling, which he said could include strict NEW guidelines, and FDA oversight, ..,ONE of FEW GLOBALLY who've received FDA inspection/APPROVED facility for the cultivation of cannabis and derivative products and DEA import permits for cannabis products..